COMMUNIQUÉS West-GlobeNewswire

Helix BioPharma Corp. Closes Private Placement
30/05/2019
RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Indus Holdings, Inc. Reports Record Revenue in the First Quarter 2019 Financial Results
30/05/2019
Indus reports revenue of $6.4 million, representing 180% revenue growth year over year SALINAS, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically integrated [...]
Eve & Co Announces Second German Supply Agreement; Provides Update on First German Supply Agreement
29/05/2019
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered into [...]
GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019)
29/05/2019
-- Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions -- Foster City, Calif. and Mechelen, Belgium; May 29, 2019; 22.30 CET - Gilead [...]
electroCore Announces Comprehensive Redeployment and Cost Reduction Plan
29/05/2019
Management to host conference call and webcast at 8:30am ET on Thursday, May 30 BASKING RIDGE, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, [...]
Aptose Announces Proposed Public Offering of Common Shares
29/05/2019
SAN DIEGO and TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it has commenced an underwritten public offering of its Common [...]
Xenon Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
29/05/2019
BURNABY, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer [...]
Myovant Sciences Announces $100 Million Public Offering of Common Shares
29/05/2019
BRISBANE, Calif. and BASEL, Switzerland, May 29, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) (“ Myovant ”), a clinical-stage healthcare company focused on developing and commercializing innovative therapies [...]
Supernus to Present at the Jefferies 2019 Global Healthcare Conference
29/05/2019
ROCKVILLE, Md., May 29, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Kane Biotech to Showcase Technologies and Products at the 2019 BIO International Convention
29/05/2019
WINNIPEG, Manitoba, May 29, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Amicus Therapeutics Announces Public Offering of Common Stock
29/05/2019
CRANBURY, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced it has commenced a $150 million underwritten public offering of its common stock. J.P. Morgan Securities LLC, Goldman [...]
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29/05/2019
RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic [...]
Synthorx to Present at Jefferies 2019 Healthcare Conference
29/05/2019
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]
Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
29/05/2019
HOUSTON, May 29, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) , a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Guardant Health to Present at the William Blair 2019 Growth Stock Conference
29/05/2019
REDWOOD CITY, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
29/05/2019
HAMILTON, Bermuda, May 29, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the following investor conferences in June: Jefferies 2019 Global Healthcare [...]
Trevena to Participate in Upcoming Conferences in June 2019
29/05/2019
CHESTERBROOK, Pa., May 29, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous [...]
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award
29/05/2019
NOVATO, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]
Bhang Corporation Appoints Former Top Spirits Executive Tom Stein as President and Announces Hiring of Two Key Executive Roles
29/05/2019
Global house of cannabis brands taps Samantha Ford Collins as Chief Marketing Officer and Jeremy Applen as Chief Science and Procedures Officer to support rapid portfolio and vertical expansion program growth MIAMI, May [...]

Pages